For DFI, high-expressed HOXC10 increased the risk of poor prognosis in LGG, LUAD, and ACC but decreased the risk of poor prognosis in KIRP, UCS, PCPG, and BLCA (Figure 1D). Here, HOXC10 is linked to adrenal cortex carcinoma.